Calyx Café is an interview series that brings together industry experts to discuss clinical research trends, futurology, and best practices to reliably solve the complex—all within the time it takes to drink a cup of coffee. Sylvain Berthelot, Senior Voice of Customer & Strategy Director at Calyx, hosts the series and has a knack for highlighting the extraordinary.
In this episode Rob Delaney, Assoc. Director of Clinical Supply Systems at Regeneron discusses what it takes to form successful sponsor/vendor relationships. Focusing on three critical elements: quality, customer service, and transparency, he explains why sponsors need to hold themselves to the same standards as their service providers in order for partnerships to work.
6 Oct 2022
Seeing the Patient beyond the Data
In this episode, Patient Advocate Emily Epstein discusses the importance of supporting clinical trial patients’ mental health and the impact that clinical trial technologies – including DCTs – may have on patient welfare.
22 Sept 2022
Physician-centricity
In this episode, Zina Sarif, Cancer Scientist and founder of Yendou talks about the importance of identifying and incentivizing more physicians to participate in clinical trials, to improve patient recruitment and ultimately, accelerate the development of life-saving treatments.
6 Sept 2022
Improving response evaluation in oncology trials
RECIST expert Dr. Oliver Bohnsack discusses a recent study that demonstrated the survival benefit to a subgroup of patients when irRECIST is used instead of RECIST 1.1 for image assessment in solid tumor trials, as irRECIST takes the entire tumor burden, including new tumor growth, into consideration.
6 Sept 2022
Accelerating Recruitment through Community Partnerships
In this episode, Brad Hightower of Hightower Clinical Research discusses the benefits of partnering with private practices to diversify clinical trial landscapes and ultimately enroll more clinical trial patients, faster.
9 Aug 2022
The Promise of Artificial Intelligence in eCOA
In this episode, Willie Muehlhausen discusses how advances in Artificial Intelligence can improve patient eCOA interactions, simplify their #clinicaltrial participation and deliver more valid data to study sponsors.
9 Aug 2022
Data Management in a DCT World
In this episode, Jen Stewart, ED Clinical Data Science at Premier Research explains the data management considerations of today’s decentralized clinical trials and how the industry could benefit from more transparency into outcomes and lessons learned as we strive to leverage remote technologies to accelerate clinical development in a post-pandemic era.
9 Aug 2022
Balancing Innovation, Scalability, and Flexibility in eClinical Sourcing
In this episode, Astra Zeneca Head of Technology Alliances, Kay Smith discusses sourcing eClinical solutions in the ever-changing tech landscape and how sponsors and providers can work together to reduce patient/site burden during clinical trials.
9 Aug 2022
Aligning Site and Sponsor Objectives
Sr. CRA Tom Miller discusses why clinical trial sponsor’s and investigative site’s objectives may not align and suggests how technology and open communication can bridge gaps to ensure both organization’s success.
9 Aug 2022
Craig Mooney: Data, Data, Who Owns the Data?
Calyx’s Craig Mooney reflects on recent changes in the regulatory landscape that emphasize the investigative site’s ownership of IRT data collected during clinical trials, and considerations for sponsors and solution providers for making progress toward this goal.
9 Aug 2022
Elizabeth Dalton: Supporting the Ultimate Customer
Calyx’s Liz Dalton discusses how CROs and their partners can best work together to find the solution to the industry’s ongoing clinical development challenge: How can we move faster, yet still safely, to bring new drugs to patients faster?
9 Aug 2022
Steve Palmatier: Partial Unblinding, Real Risks
Rho’s Steve Palmatier describes how partial unblinding occurs and how advanced IRT systems can reduce these very real risks to ensure data quality isn’t compromised.
9 Aug 2022
No Such Thing as "Clone and Go"
Merck’s Joseph McDonnell and Jeffrey Timmons discuss the company’s spinoff of Organon, how the separate organizations are creating value for all stakeholders, and why they’re excited about the role of technology in streamlining the regulatory process.
9 Aug 2022
Karen Harry: Ready or Not, Here IDMP comes...
Karen Harry explains what market authorization holders can expect as they prepare to transition their Centrally Approved Product (CAP) submissions to IDMP Iteration 1.
9 Aug 2022
Understanding the Machine: Can Humans and AI Work Together?
9 Aug 2022
Willie Meuhlhausen: To BYOD or not to BYOD
Hear from Willie Muehlhausen about the growing usage of BYOD, patient preferences, and what regulators have to say about this approach to collecting PRO data in clinical trials.
9 Aug 2022
Morris Panner: Progressing Healthcare and Research through AI
In this episode, Morris Panner of Ambra Health talks about first-time quality and how the continuous bursts of innovation in agile cloud technology and AI are opening opportunities to progress clinical research and enable greater access to healthcare.
By leveraging today’s data capture technologies –like advanced medical imaging –HCPs can enhance measurement quality and capture real-time data points to intervene before patients leave the site, improving clinical trial recruitment/engagement and, ultimately, patient care.
9 Aug 2022
Malcolm Morrissey: Reducing Drug Waste through IRT | Calyx Café
Contact Calyx Cafe
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Calyx Cafe?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
